Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 55.00K | 38.00K | 22.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.00K | 38.00K | 22.00K | -- | -- |
| Cost of Revenue | 31.32M | 33.59M | 37.59M | 37.60M | 35.74M |
| Gross Profit | -31.27M | -33.55M | -37.56M | -37.60M | -35.74M |
| SG&A Expenses | 20.32M | 19.76M | 19.01M | 20.53M | 18.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.64M | 53.34M | 56.59M | 58.13M | 54.52M |
| Operating Income | -51.59M | -53.31M | -56.57M | -58.13M | -54.52M |
| Income Before Tax | -49.56M | -51.55M | -61.44M | -47.58M | -58.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.56 | -51.55 | -61.44 | -47.58 | -58.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.56M | -51.55M | -61.44M | -47.58M | -58.32M |
| EBIT | -51.59M | -53.31M | -56.57M | -58.13M | -54.52M |
| EBITDA | -48.44M | -49.91M | -52.94M | -54.45M | -50.79M |
| EPS Basic | -1.77 | -1.92 | -3.19 | -3.34 | -8.95 |
| Normalized Basic EPS | -1.13 | -1.22 | -1.88 | -1.75 | -2.84 |
| EPS Diluted | -1.77 | -1.92 | -3.19 | -3.34 | -8.95 |
| Normalized Diluted EPS | -1.13 | -1.22 | -1.88 | -1.75 | -2.84 |
| Average Basic Shares Outstanding | 115.73M | 110.66M | 89.70M | 66.98M | 45.33M |
| Average Diluted Shares Outstanding | 115.73M | 110.66M | 89.70M | 66.98M | 45.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |